Cognitive decline tracking company Neurotrack has raised $9.9 million in a new round of equity financing, according to an SEC filing posted this week. Palo Alto, Calif.-based Neurotrack’s 1st product is the Imprint, a digital cognitive assessment test designed to track cognitive decline and help advance research and treatment of cognitive diseases like Alzheimers. The […]